News about Global Pharma

Moderna and Mitsubishi Tanabe Pharma to Promote mRNA Respiratory Vaccine in Japan

Moderna, Inc. has signed a joint agreement with Mitsubishi Tanabe Pharma regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including Moderna's COVID-19 vaccine, Spikevax.

Global Pharma | 15/07/2024 | By Aishwarya |  613

BARDA and Tiba Biotech to Develop Innovative Therapeutics Against Influenza

Tiba Biotech has joined hands with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) at the US Department of Health and Human Services (HHS).

Global Pharma | 12/07/2024 | By Aishwarya |  591

AusperBio Gets BTD for AHB-137 in Chronic Hepatitis B Treatment

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. have announced that their investigational drug AHB-137 has received Breakthrough Therapy Designation (BTD) from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China.

Global Pharma | 11/07/2024 | By Aishwarya |  961

Promoters of Sudeep Pharma Completes Acquisition from JRS Pharma

Sudeep Pharma Pvt. Ltd.’s promoters have completed the acquisition of shares from their joint venture partners – JRS PHARMA, regaining 100 percent ownership of the company.

Global Pharma | 11/07/2024 | By Aishwarya |  562

Sanofi Starts Shipping US Influenza Vaccines for 2024-25

Sanofi has begun shipped its first influenza (flu) vaccines across the U.S. in preparation for the 2024–25 flu season.

Global Pharma | 11/07/2024 | By Aishwarya |  1396

Pint Pharma Announces Approval of ORLADEYO in Peru

Pint Pharma has announced that the General Directorate of Medicines Supplies and Drugs (DIGEMID) in Peru has announced the approval of ORLADEYO (berotralstat) for prophylaxis of hereditary angioedema (HAE) attacks in adults and children 12 years and older.

Global Pharma | 10/07/2024 | By Aishwarya |  731

Life Molecular Imaging Expands Partnership with Jubilant Radiopharma to Distribute Neurace

Life Molecular Imaging (LMI) has expanded their strategic partnership and licensing agreement with Jubilant Radiopharma to provide and distribute Neuraceq from Jubilant's single photon emission computed tomography (SPECT) and Positron Emision Tomography (PET) radiopharmaceutical manufacturing site located in Mobile, AL.

Global Pharma | 10/07/2024 | By Aishwarya |  879

MedPharm Announces Merger with Tergus Pharma

MedPharm, Ltd. has announced a merger with Tergus Pharma, a Great Point Partners portfolio company.

Global Pharma | 10/07/2024 | By Aishwarya |  731

TuHURA Biosciences Signs Exclusivity and Right of First Offer Deal for Kineta

TuHURA Biosciences, Inc. has entered into an Exclusivity and Right of First Offer Agreement with Kineta, Inc. for the potential acquisition of Kineta's KVA12123 anti-VISTA antibody and related rights and assets associated with and derived from the asset.

Global Pharma | 09/07/2024 | By Aishwarya |  657

CASI Pharmaceuticals Appoints Daniel Lang as New CFO and SVP

CASI Pharmaceuticals, Inc. has appointed Daniel Lang, MD as Chief Financial Officer and Senior Vice President.

Global Pharma | 09/07/2024 | By Aishwarya |  974